Research & Further Reading
Scientific studies, publications and material for readers who want to explore the evidence in greater depth.
Experimental hemodialysis in diet-induced ketosis and the potential use of dialysis as an adjuvant cancer treatment
Read the journal article →Dialysis as a Novel Adjuvant Treatment for Malignant Cancers
Read the journal article →Questions & Perspectives
Glutamine Under Hypoxia: More Than Fuel
Glucose and oxygen dominate most discussions of tumor metabolism, but glutamine deserves special attention. Its role changes with the oxygen available to the cell.
Read the note →LDH: Tumor Stress, Not Mitochondrial Failure
Lactate dehydrogenase (LDH) is linked to aggressive cancer, but what exactly does a high LDH level tell us?
Read the note →Survival Before Proliferation: Life in a Nutrient-Limited Tumor
Cancer is usually discussed in terms of proliferation. Yet there is something more fundamental: before a tumor cell can divide, it must survive.
Read the note →Metabolic Cooperation in Tumors – Can Glucose Deprivation Disrupt It?
Within the complex tumor microenvironment, cancer cells cooperate metabolically in a fascinating way.
Read the note →Understanding Tumor Hypoxia and Treatment Resistance
Low oxygen levels are a major challenge in solid tumors. Hypoxia influences responses to radiotherapy, some chemotherapies, immunotherapy and targeted treatments — although the mechanisms are not identical for every therapy.
Read the note →Ketones Preserve T-Cell Effector Function in a Glucose-Poor Tumor Environment
Tumor-infiltrating T cells must fight cancer in an environment where glucose is often scarce. An important question is whether ketones can sustain their ability to kill cancer cells when glucose availability is severely restricted.
Read the note →FAO Inhibitors: Are We Targeting the Tumor—or the Host?
Williams and colleagues (2025) described metabolic communication between triple-negative breast cancer cells and neighboring adipocytes. Their work raises a larger question: when fatty acid oxidation (FAO) is inhibited in a living animal, how much of the antitumor effect comes from the tumor itself—and how much from the rest of the body?
Read the note →When Adaptation Becomes a Trap
An adaptation that enables survival can become a disadvantage when conditions change. Could the same be true for tumor metabolism?
Read the note →Cancer Metabolism: Which Comes First—Genes or Environment?
Cancer metabolism is often described as the result of oncogenic mutations: altered genes produce altered metabolism. But in the living tumor, the environment also determines which genes are expressed and which metabolic pathways are used. Are we giving the environment enough credit?
Read the note →Cancer Metabolism: Defective Mitochondria—or Too Little Oxygen?
Why do many cancer cells rely so strongly on glycolysis? Thomas Seyfried argues that mitochondrial dysfunction is central to cancer metabolism. We agree that glucose dependence is a potential metabolic vulnerability. We differ on its underlying cause: I believe oxygen, glucose and lactate delivery deserve at least as much attention as the mitochondria themselves.
Read the note →